New York, NY, United States of America

Sarah M Cheal

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 5.3

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2020-2024

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Sarah M Cheal

Introduction

Sarah M Cheal is a prominent inventor based in New York, NY, known for her significant contributions to the field of biomedical research. With a total of five patents to her name, she has made remarkable strides in the development of multi-specific antibodies and cancer treatment methodologies. Her work is particularly focused on addressing diseases characterized by the expression of the A33 glycoprotein antigen, notably colorectal cancer.

Latest Patents

One of her latest patents is titled "Multi-specific antibodies with affinity for human A33 antigen and DOTA metal complex and uses thereof." This patent describes multi-specific binding agents that target A33 and 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid. The patent also outlines methods for using these binding agents in the detection, prevention, and therapeutic treatment of diseases associated with the A33 glycoprotein antigen. Another significant patent is "Dota-hapten compositions for anti-dota/anti-tumor antigen bispecific antibody pretargeted radioimmunotherapy." This disclosure provides innovative compositions and methods for cancer detection and treatment, including novel DOTA-haptens that can be complexed with radioisotopes for diagnostic imaging and pretargeted radioimmunotherapy.

Career Highlights

Throughout her career, Sarah has worked with esteemed institutions such as Memorial Sloan Kettering Cancer Center and the Massachusetts Institute of Technology. Her experience in these prestigious organizations has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of her notable coworkers include Steven M Larson and Hong Xu, who have played significant roles in her research endeavors. Their collaborative efforts have further advanced the understanding and treatment of cancer.

Conclusion

Sarah M Cheal's innovative work in the field of biomedical research has led to significant advancements in cancer treatment and detection. Her contributions through her patents and collaborations continue to impact the medical community positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…